GlassScriptPhysician profile
Robert James Wilcott
NPI 1073559209
$25,139.62
in general payments reported to CMS, 2019-2025
15 companies · $54.75 in 2025
The $54.75 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $2,330 · 2021: $16K · 2022: $4,409 · 2023: $339 · 2024: $23.89 · 2025: $54.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380 · Travel and Lodging: $38.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.73 |
| Travel and Lodging | $38.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,519.62 | 2020-2023 | Da Vinci Surgical System |
| Atricure, INC. | $3,098.31 | 2019-2023 | |
| Silk Road Medical, INC. | $1,104.84 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Steris Corporation | $1,086.69 | 2020 | |
| Medtronic Vascular, INC. | $979.59 | 2019 | |
| Medtronic, INC. | $949.20 | 2021-2022 | |
| Abiomed | $143.05 | 2020-2023 | Impella |
| Cvrx, INC. | $78.64 | 2024-2025 | Barostim Neo System |
| Ethicon US, LLC | $39.81 | 2023 | Echelon; Endopath, Echelon Endopath |
| Potrero Medical, INC. | $31.63 | 2022 | |
| W. L. Gore & Associates, INC. | $27.43 | 2019 | |
| Contego Medical, INC | $24.86 | 2023 | |
| Covidien LP | $22.65 | 2019 | |
| Kci USA, INC. | $17.71 | 2019 | |
| Biomerieux INC | $15.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.